US20200406030A1 - Implantable electrical stimulator - Google Patents
Implantable electrical stimulator Download PDFInfo
- Publication number
- US20200406030A1 US20200406030A1 US17/022,832 US202017022832A US2020406030A1 US 20200406030 A1 US20200406030 A1 US 20200406030A1 US 202017022832 A US202017022832 A US 202017022832A US 2020406030 A1 US2020406030 A1 US 2020406030A1
- Authority
- US
- United States
- Prior art keywords
- electrodes
- stimulator
- muscle
- nerve
- implantable stimulator
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000003205 muscle Anatomy 0.000 claims abstract description 99
- 210000005036 nerve Anatomy 0.000 claims abstract description 69
- 238000005259 measurement Methods 0.000 claims abstract description 22
- 230000004936 stimulating effect Effects 0.000 claims abstract description 18
- 238000002567 electromyography Methods 0.000 claims abstract 3
- 238000000034 method Methods 0.000 claims description 36
- 230000000638 stimulation Effects 0.000 claims description 23
- 230000003213 activating effect Effects 0.000 claims description 7
- 230000004044 response Effects 0.000 claims description 7
- 230000005540 biological transmission Effects 0.000 claims description 5
- 230000008602 contraction Effects 0.000 claims description 4
- 230000010339 dilation Effects 0.000 claims description 3
- 210000003800 pharynx Anatomy 0.000 claims description 3
- 201000002859 sleep apnea Diseases 0.000 claims 4
- 230000004118 muscle contraction Effects 0.000 claims 2
- 239000002243 precursor Substances 0.000 claims 2
- 238000004891 communication Methods 0.000 description 12
- 208000001797 obstructive sleep apnea Diseases 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 9
- 238000002513 implantation Methods 0.000 description 7
- 230000036982 action potential Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000029058 respiratory gaseous exchange Effects 0.000 description 6
- 230000004913 activation Effects 0.000 description 5
- 239000003990 capacitor Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000010586 diagram Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000007383 nerve stimulation Effects 0.000 description 4
- 238000003491 array Methods 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 210000001611 motor endplate Anatomy 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 206010041235 Snoring Diseases 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 210000001169 hypoglossal nerve Anatomy 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 210000000715 neuromuscular junction Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 230000005236 sound signal Effects 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 208000010444 Acidosis Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000004696 Poly ether ether ketone Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000007950 acidosis Effects 0.000 description 1
- 208000026545 acidosis disease Diseases 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- JUPQTSLXMOCDHR-UHFFFAOYSA-N benzene-1,4-diol;bis(4-fluorophenyl)methanone Chemical compound OC1=CC=C(O)C=C1.C1=CC(F)=CC=C1C(=O)C1=CC=C(F)C=C1 JUPQTSLXMOCDHR-UHFFFAOYSA-N 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000012966 insertion method Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910001416 lithium ion Inorganic materials 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 210000002161 motor neuron Anatomy 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920002530 polyetherether ketone Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229910000859 α-Fe Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3601—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of respiratory organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0551—Spinal or peripheral nerve electrodes
- A61N1/0553—Paddle shaped electrodes, e.g. for laminotomy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/375—Constructional arrangements, e.g. casings
- A61N1/3756—Casings with electrodes thereon, e.g. leadless stimulators
Definitions
- the selection is performed by the electrode array measuring electrical parameters through one or more electrodes or group of electrodes and making a selection based on the results of said measurements.
- FIG. 3A is a schematic illustration of a flexible electrode array shaped as a tent, according to an exemplary embodiment of the invention.
- FIG. 5 is a flow diagram of a method of using a stimulator, according to an exemplary embodiment of the invention.
- the communications and/or power transfer are performed using a non-standard protocol to prevent interference from standard communication equipment.
- standard communication protocols may be used, for example communicating with WIFI, BlueTooth (BT), RF or other common standards so that stimulator 100 can readily communicate with standard equipment that is readily available, such as personal computer 180 or a cellular telephone (e.g. using BT).
- communications with stimulator 100 may be encrypted and/or require authentication to prevent undesirable transmissions from non-authorized users.
- a predefined range of transmission frequencies is used so it will not interfere or receive interference from other radio emitting devices.
- elements 220 are electronically connected by flexible wires 210 , thus providing a larger overall flexible stimulator 200 .
- elements 270 are connected to a flexible communication bus 280 , forming an overall flexible stimulator 280 .
- a flexible stimulator is less apt to be damaged by external forces and can be more easily manipulated to fit into various positions inside the patients body.
- a flexible stimulator such as shown in FIGS. 2A or 2B will also allow free 3D movement of an organ (e.g. muscle) without causing damage.
- the flexible connection between the elements enables the elements to be freely positioned relative to each other and effectively allow bending or folding of stimulator 100 .
- FIG. 3D is a schematic illustration of flexible electrode array 300 implanted at the base of the tongue, according to an exemplary embodiment of the invention.
- electrode array 300 is designed so that when it is deployed, electrodes 310 will be in contact with the Genioglossus muscle 350 and more specifically adjacent to the Genioglossus horizontal fibers 350 and/or near the Hypoglossal nerves 360 , so that electrodes 310 will successfully be able to stimulate the Genioglossus horizontal compartment causing dilation of the pharynx during breathing.
- the shape of electrode array 300 is especially efficient in stimulating the Genioglossus muscle 350 , as this muscle has numerous motor end plates, located in various locations in contrast to many other muscles.
- stimulator 100 is advantageous since the multiplicity of electrodes relative to the number of contact points on the muscle/nerve and the ability to select the optimal electrodes for stimulation after implantation, reduce the need to adjust the position of stimulator 100 responsive to actual stimulation during the insertion process.
- An example of use of a stimulator 100 is in dealing with Obstructive Sleep Apnea patients.
- stimulator 100 is implanted in the vicinity of the Hypoglossal nerve using a shallow transcutaneous approach. In other cases stimulator 100 is implanted into the Genioglossus muscle using an intraoral or transcutaneous/submandibular approach.
- Temperature in the vicinity of stimulator 100 for example a higher temperature value responsive to the patient expiration in the vicinity of the implanted stimulator 100 and a lower temperature value responsive to the patient inspiration in the vicinity of stimulator 100 .
- a decrease in the temperature change may indicate reduction in breathing;
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physiology (AREA)
- Pulmonology (AREA)
- Electrotherapy Devices (AREA)
Abstract
Description
- The present invention relates generally to an implantable electrical stimulator and more specifically to an implantable electrical stimulator with a dynamically controlled electrode array.
- Implanting a stimulator to stimulate muscles or nerves is a complex procedure. Generally in the case of nerve stimulation, a special electrode is used, such as a cuff electrode. Generally the electrode is in the form of a wire extending from the stimulator to the nerve. Implantation of the stimulator requires surgical intervention to expose the position for implanting the electrode and stimulator and then requires fine-tuning the placement of the electrode so that accurate contact will be formed between the electrodes of the stimulator and specific contact points along the muscles or nerves.
- In the case of muscle stimulators, the electrodes are typically positioned to form contact with the motor end plate of a muscle, also called the neuromuscular junction of the muscle. In most muscles the motor end plate is located in the middle of the muscle, where the motor neuron interfaces with the muscle.
- In recent years manufactures have managed to reduce the size of stimulators significantly, for example to approximately 3 mm by 27 mm. In a reduced size stimulator the electrode may be provided as a rigid metal contact extending from the body of the stimulator and the stimulator is implanted with the electrode positioned in contact with the muscle/nerve contact points.
- One method to achieve the correct positioning is by trial and error, wherein the practitioner inserts the stimulator to a selected position and then provides a charge to the electrodes of the stimulator to verify the position according to the response of the muscles, for example contraction of the entire muscle indicates a successful positioning and local contraction indicates an unsuccessful positioning. This method requires a high level of expertise from the practitioner and may be very time consuming.
- Another method suggests the use of a probe that also serves as the introduction device for the stimulator. The practitioner uses the probe to locate the desired position and then uses the probe to insert the stimulator to the located position.
- Some problems may occur after positioning the stimulator. One problem is that a rigid stimulator may damage the muscles/nerves or surrounding tissue and lead to complications, for example causing inflammation, which may reduce tissue conductivity, so that the stimulator device may not stimulate the muscles/nerves properly. A second problem that may occur is movement of the stimulator and/or electrodes, which may cause a shift in the electrode alignment. The shift in the electrode alignment may reduce stimulation of the muscles/nerves thus preventing the stimulator from effectively causing tissue stimulation.
- U.S. Pat. No. 7,447,551 to Kuo et al. the disclosure of which is incorporated herein by reference describes using a flexible circuit board in creating an implantable stimulator. The stimulator is coated with a flexible bio-compatible package material to enhance safety, durability and reliability of the implantable stimulator. Kuo further discloses using an array of electrodes to enlarge the electrical treatment area and improving the electrical treatment efficiency.
- An aspect of an embodiment of the invention, relates to an implantable stimulator for stimulating muscles and/or nerves, with a dynamically controllable array of electrodes. The array of electrodes is made up from one or more rows and one or more columns of electrodes positioned on a surface that can be placed in contact with a muscle/nerve. Optionally, the stimulator may have multiple arrays, for example one on each side of the stimulator or even multiple arrays on each side of the stimulator. In an exemplary embodiment of the invention, the array of electrodes has a density greater than the density of the muscle/nerve contact points, which need to be stimulated; or the array of electrodes occupies an area larger than that of the muscle/nerve contact point. In any of the above two options, once the stimulator is initially positioned at least some of the electrodes will coincide with the position of the contact points.
- In an exemplary embodiment of the invention, the stimulator automatically determines which electrodes are in contact with points on the muscle/nerve wherein the action potentials signals measured at those points indicates that they are desirable contact points. The properties measured for an action potential signal may include among other details: frequency, amplitude, and propagation speed. Optionally, when relating to muscle stimulation, the contact points are generally located in the motor units, which include the neuromuscular junction.
- In an exemplary embodiment of the invention, the method of selecting a specific electrode or group of electrodes may include measuring the action potentials amplitudes, and creating time integrals, for example by using Root Mean Square to determine the location of the muscle's Motor Units. Alternatively or additionally, other algorithms, such as decomposition algorithms, or Correlation Kernel Compensation, may help to determine the location of the muscle's Motor Units. Optionally, the electrodes that are close or in contact with the muscles Motor Units are selected as having measured the lowest resistance at the electrode contact point and those electrodes are used to stimulate the muscles/nerves of the patient. Optionally, the determination may be made periodically or upon request of the patient or practitioner. In an alternative embodiment of the invention, the practitioner that installs the stimulator, communicates with the stimulator wirelessly using a computer and selects the electrodes that elicit the most prominent clinical reaction.
- In an exemplary embodiment of the invention, the array of electrodes is used to identify contracting regions. The controller in the stimulator can then choose to stimulate the contracting regions or the non-contracting regions.
- In some embodiments of the invention, the electrodes serve as inputs and outputs. Alternatively, some of the electrodes serve as inputs and some serve as outputs. Optionally, the inputs measure the resistance or electrical activity of the muscle/nerve at their contact point with the muscle/nerve.
- In some embodiment of the invention, the stimulator is made up from a few basic rigid elements, for example an integrated circuit to control the stimulator, a memory chip, a power source (e.g. a battery), a transceiver and other elements. Optionally, each element is wrapped separately in a bio-compatible encasement and connected with flexible wiring or a common flexible backbone serving as a communication bus between the elements of the stimulator, thus providing a flexible stimulator, In an exemplary embodiment of the invention, the electrodes are provided as a separate element made up from an array of contacts on a flexible material, for example, wherein the material is made up from Polyimide, Polyester or PEEK thermoplastic with the electrodes embedded in it.
- There is thus provided according to an exemplary embodiment of the invention, an implantable stimulator for stimulating muscles or nerves, including:
- an array of electrodes for electrically stimulating muscles or nerves;
- a controller for controlling the activity of the electrodes;
- wherein the controller is adapted to dynamically select the electrodes that are used to participate in stimulating the muscles or nerves.
- Optionally, the implantable stimulator further includes a power source to power the stimulator.
- In an exemplary embodiment of the invention, the implantable stimulator further includes a transceiver to wirelessly communicate with external devices and receive commands for the controller.
- Optionally, the controller selects the electrodes responsive to a communication from an external device.
- In an exemplary embodiment of the invention, the controller periodically updates the selection of electrodes to participate in stimulation of the muscle or nerve.
- Optionally, the controller selects the electrodes responsive to a determination made by electrical measurements made by the electrodes.
- In an exemplary embodiment of the invention, substantially all the electrodes can serve as inputs to measure electrical activity in the muscles or nerves and as outputs to electrically stimulate the muscles or nerves.
- Optionally, some of the electrodes serve as inputs to measure electrical activity in the muscles or nerves and some of the electrodes serve as outputs to electrically stimulate the muscles or nerves.
- In an exemplary embodiment of the invention, the density of the array of electrodes is greater than the density of the active contact points of the muscle or nerve being stimulated by the stimulator.
- Optionally, the array of electrodes is connected by flexible wires to the other elements of the stimulator.
- In an exemplary embodiment of the invention, the stimulator is made up from multiple independent parts connected together electrically by a flexible connection.
- Optionally, the stimulator is made up from flexible material. In an exemplary embodiment of the invention, the array of electrodes forms a three-dimensional shape shielding the controller in said three-dimensional shape.
- In an exemplary embodiment of the invention, the implantable stimulator further includes a housing, and said controller is located within the housing.
- Optionally, the implantable stimulator further includes a housing, and the controller, and the power source are located within the housing.
- In an exemplary embodiment of the invention, the stimulator is adapted to be implanted at the base of a person's tongue.
- Optionally, the implantable stimulator further includes sensors to sense physiological parameters of the person with the implanted stimulator.
- In an exemplary embodiment of the invention, the sensors are adapted to sense physical parameters from the group consisting of temperature, vibrations, and audio signals.
- Optionally, the stimulator is activated responsive to measurements received by the sensors.
- In an exemplary embodiment of the invention, the power source receives power wirelessly.
- There is further provided according to an exemplary embodiment of the invention, a method of stimulating muscles or nerves using an implantable stimulator with an array of electrodes, including:
- dynamically selecting the electrodes that will participate in stimulating the muscle or nerve from the available electrodes; and
- activating the selected electrodes to stimulate a muscle or nerve.
- In an exemplary embodiment of the invention, the method further includes implanting the stimulator so that the array of electrodes is in proximity with a muscle or nerve.
- Optionally, the selection is performed manually by a practitioner by communicating with the stimulator and instructing the stimulator to activate one or more electrodes or groups of electrodes while observing the response.
- Alternatively or additionally, the selection is performed by the electrode array measuring electrical parameters through one or more electrodes or group of electrodes and making a selection based on the results of said measurements.
- Optionally, the selection is performed by the electrode array measuring electrical parameters through an external device.
- In an exemplary embodiment of the invention, the selection is repeated periodically.
- Optionally, the selection is activated responsive to inputs accepted by the stimulator.
- In an exemplary embodiment of the invention, the selection is activated responsive to sensor input.
- Optionally, dynamically selecting further includes performing a pre-programmed algorithm to weigh the results from various inputs and determining whether to provide stimulation.
- In an exemplary embodiment of the invention, the method further includes determining the specific stimulation protocol to provide.
- Optionally, the dynamic selection is responsive to electrical measurements at the location of the electrodes.
- In an exemplary embodiment of the invention, the dynamic selection is responsive to responsiveness of the nerve or muscle at the location of the electrodes.
- Optionally, the method further includes adjusting the stimulator responsive to a measurement before activating the stimulator.
- In an exemplary embodiment of the invention, the stimulation is provided at specific times, for specific time duration, or periodically.
- The present invention will be understood and better appreciated from the following detailed description taken in conjunction with the drawings. Identical structures, elements or parts, which appear in more than one figure, are generally labeled with the same or similar number in all the figures in which they appear, wherein:
-
FIG. 1 is a schematic illustration of a block diagram of an electrical stimulator, according to an exemplary embodiment of the invention; -
FIG. 2A is a schematic illustration of an electrical stimulator with independent elements connected by flexible wires, according to an exemplary embodiment of the invention; -
FIG. 2B is a schematic illustration of an electrical stimulator with independent elements connected by a flexible backbone serving as a communication bus, according to an exemplary embodiment of the invention; -
FIG. 3A is a schematic illustration of a flexible electrode array shaped as a tent, according to an exemplary embodiment of the invention; -
FIG. 3B is a schematic illustration of a flexible electrode array shielding beneath it other elements connected together by a flexible wire, according to an exemplary embodiment of the invention; -
FIG. 3C is a schematic illustration of a flexible electrode array shielding beneath it other elements connected together by a flexible communication bus, according to an exemplary embodiment of the invention; -
FIG. 3D is a schematic illustration of a flexible electrode array implanted at the base of the tongue, according to an exemplary embodiment of the invention; -
FIG. 4A is a schematic illustration of a flexible electrode array shaped as a flat surface, according to an exemplary embodiment of the invention; -
FIG. 4B is a schematic illustration of a flexible electrode array shaped as a cylinder, according to an exemplary embodiment of the invention; -
FIG. 4C is a schematic illustration of a flexible electrode array shaped as a 3 dimensional curved surface with electrodes on the inner side, according to an exemplary embodiment of the invention; -
FIG. 4D is a schematic illustration of a flexible electrode array with branches of electrodes extending from a common center, according to an exemplary embodiment of the invention; -
FIG. 4E is a schematic illustration of a flexible electrode array with branches of electrodes of various sizes extending from a common center, according to an exemplary embodiment of the invention; and -
FIG. 5 is a flow diagram of a method of using a stimulator, according to an exemplary embodiment of the invention. -
FIG. 1 is a schematic illustration of a block diagram of anelectrical stimulator 100, according to an exemplary embodiment of the invention. In an exemplary embodiment of the invention,stimulator 100 includes anelectrode array 110, which is designed to be placed in contact with the contact points of nerves or muscles, or in proximity thereof, so that the electrodes can stimulate the contact points. Optionally, the electrode array is denser than the contact points on the muscle or nerve (e.g. 1-100,000 electrodes per millimeter, or per centimeter) or the array of electrodes occupies an area larger than that of the muscle/nerve contact point, so that each contact point on the muscle or nerve that needs to be stimulated will have one ormore electrodes 115 in contact with it. In some embodiments of the present invention, some or all of the electrodes can be placed in proximity with the contact points of nerves or muscles. In the context of the present invention placed, includes, but is not limited to implanted, inserted, injected, wrapped, and in any other way positioned in contact or in proximity to contact points of nerves or muscles. In some embodiments of the invention, the tips of the electrodes that are in contact with the patients tissue may be any shape, for example circular or rectangular. Optionally, the tip may be flat or rounded to preventelectrode array 110 from getting stuck if placed in contact with the patient's tissue before reaching its final position. Alternatively, the tips of the electrode may be coated with materials that encourage tissue fibrosis. Alternatively, the tips may be thorn like to anchorstimulator 100. In an exemplary embodiment of the invention,electrodes 115 are made of or plated with a bio-compatible metal (e.g. a noble metal like platinum or gold). - Optionally, the shape of
electrode array 110 is selected based on the type of nerve or muscle needed to be stimulated. In some embodiments of the invention, the shape may be one dimensional (e.g. a line of electrodes), two dimensional or three dimensional. - In an exemplary embodiment of the invention, an
electrode array controller 120 is used to control theelectrodes 115 ofelectrode array 110. Optionally,electrode array controller 120 can be used to select or deselect any of theelectrodes 115, so that whenstimulator 100 outputs a stimulation pulse the selected electrodes will output the pulse. In some embodiments of the invention, some electrodes are output electrodes and some are input electrodes. Alternatively, the electrodes can be selected to be either input or output. Optionally,electrode array controller 120 can use input electrodes as input sensors, for example to serve as an electromyograph (EMG), detecting the resistance/conductivity or action potential of the muscles/nerves in contact with a specific electrode. Optionally, such a measurement can be used to locate the desired area for stimulation of the muscle or nerve and determine whichelectrodes 115 are in contact with the desired areas. - In an exemplary embodiment of the invention, due to external forces exerted on
stimulator 100 after being embedded in a patient, the exact position of the electrode array may shift andelectrodes 115 that were previously selected to stimulate contact points may shift over and other electrodes may be in contact with the muscle/nerve contact points in their place. As explained above the electrodes participating in stimulating the muscles/nerves of the patient are dynamically selectable, so that theelectrodes 115 participating in stimulating the muscles/nerves can be reselected to overcome such problems. - In an exemplary embodiment of the invention,
stimulator 100 includes acontrol circuit 130, which includes a general purpose CPU or an application specific integrated circuit (ASIC) or the like to control the functionality of the stimulator, for example to determine when to provide a stimulation signal and the parameters of the signal, for example its frequency, pulse width, pulse shape, pulse interval and pulse duration. Optionally,control circuit 130 is preprogrammed to apply various stimulation programs, such as: - 1. A nerve stimulation program;
- 2. A muscle stimulation program; and
- 3. Biphasic stimulation that alternates polarization on the
electrodes 115 to prevent accumulation of ions and acidosis thus reducing tissue damage. - Optionally, each program may use different pulse frequency, shapes, widths, intervals, durations and other parameters for the stimulation signal applied to the electrodes.
- In some embodiments of the invention,
stimulator 100 includes amemory 140, for example a non-volatile memory that is used to store operational parameters or program code which the control circuit can act upon, - Optionally,
stimulator 100 further includes apower supply 160, which may include a rechargeable battery, for example a Li-Ion battery. Alternatively or additionally, the power supply may include a capacitor and/or coil for holding charge for a short term until charging the battery or for immediate consumption. In an exemplary embodiment of the invention, the power for using the device is provided by wireless transmission of power to apower receptor 170, for example an induction coil or RFID coil. In an exemplary embodiment of the invention,stimulator 100 may be activated as long aspower receptor 170 is accepting transmitted power. Alternatively,stimulator 100 is first charged and then activated to consume the power frompower supply 160. Further alternatively, priority is giving to the stimulation: first stimulating by passing the received power transmission directly to the stimulation circuit, and then charging. - In some embodiments of the invention,
stimulator 100 includes atransceiver 150 for communicating betweenstimulator 100 and an external device, such as apersonal computer 180 or anexternal activation device 190 that is designed to communicate withstimulator 100. - In some embodiments of the invention, the communications and/or power transfer are performed using a non-standard protocol to prevent interference from standard communication equipment. Alternatively, standard communication protocols may be used, for example communicating with WIFI, BlueTooth (BT), RF or other common standards so that
stimulator 100 can readily communicate with standard equipment that is readily available, such aspersonal computer 180 or a cellular telephone (e.g. using BT). Optionally, communications withstimulator 100 may be encrypted and/or require authentication to prevent undesirable transmissions from non-authorized users. Alternatively or additionally, a predefined range of transmission frequencies is used so it will not interfere or receive interference from other radio emitting devices. - In some embodiments of the invention,
stimulator 100 includes one ormore sensors 125 that sense various parameters such as temperature, sound, vibrations, pressure, electrical current, impedance, and the like. Alternatively or additionally,stimulator 100 receives wireless communication from sensors implanted elsewhere in the patient or located outside of the patient. Optionally, muscle/nerve stimulation can be activated responsive to the measurements ofsensors 125. In some embodiments of the invention,stimulator 100 may activate stimulation responsive to specific combinations of measurements. An example of use of an internal or external sensor occurs in dealing with Obstructive Sleep Apnea (OSA). During sleep a person inhales colder air (e.g. at room temperature of about 25° C.) and exhales warmer air (e.g. at body temperature of about 37° C.). Optionally,stimulator 100 may be planted at the base of the tongue adjacent to the air path of the patient's breath. A temperature sensor can follow the breathing pattern by following the temperature changes andalert stimulator 100 to stimulate the tongue muscles responsive to a determination that the tongue is blocking the path. Alternatively, an external sensor can be positioned over the patient's mouth or nose to keep track of the breathing pattern. - In some embodiments of the invention,
sensor 125 is used to measure the electrical current or impedance of specific electrodes to determine the importance of the specific electrode in stimulating the nerve/muscle at the current position ofstimulator 100 andelectrode array 110. -
FIG. 2A is a schematic illustration of anelectrical stimulator 200 withindependent elements 220 connected by flexible wires, according to an exemplary embodiment of the invention; andFIG. 2B is a schematic illustration of anelectrical stimulator 250 withindependent elements 270 connected by aflexible backbone 280 serving as a communication bus, according to an exemplary embodiment of the invention. In an exemplary embodiment of the invention, as illustrated above inFIG. 1 stimulator 100 is made up from various elements. Optionally, each element may comprise a rigid electronic circuit or other rigid parts (e.g. a battery, a coil, a capacitor, an integrated circuit), which communicate electronically with the other elements ofstimulator 100. In some embodiments of the invention, as illustrated inFIG. 2A bystimulator 200,elements 220 are electronically connected byflexible wires 210, thus providing a larger overallflexible stimulator 200. Alternatively, as illustrated inFIG. 2B ,elements 270 are connected to aflexible communication bus 280, forming an overallflexible stimulator 280. Optionally, a flexible stimulator is less apt to be damaged by external forces and can be more easily manipulated to fit into various positions inside the patients body. Additionally, a flexible stimulator such as shown inFIGS. 2A or 2B will also allow free 3D movement of an organ (e.g. muscle) without causing damage. Optionally, the flexible connection between the elements enables the elements to be freely positioned relative to each other and effectively allow bending or folding ofstimulator 100. - In an exemplary embodiment of the invention,
electrode array 110 is designed to match the muscle or nerve it will be interfacing.FIG. 3A is a schematic illustration of aflexible electrode array 300 shaped as a triangular tent, according to an exemplary embodiment of the invention. In an exemplary embodiment of the invention, the flexible electrode array is shaped to fit the nerve or muscle it is to be placed inside or next to. In another exemplary embodiment of the invention, the flexible electrode array is shaped to fit a recess between nerves or tissue, a compartment in muscles or between tissues, or an epimysial surface. Such recess, compartment or surface can naturally occur or be artificially created.Electrode array 300 is densely populated (e.g. between 1×1 to 1000×1000electrodes 310 per millimeter square or more, or less) and it is designed to be used to stimulate the Genioglossus muscle at the base of the tongue for treatment of Obstructive Sleep Apnea (OSA). It should be noted that the above design is not limiting and other designs can also be used for treatment of OSA. -
FIG. 3B is a schematic illustration of aflexible electrode array 300 shielding beneath itother elements 330 connected together by aflexible wire 320 andFIG. 3C is a schematic illustration of aflexible electrode array 300 shielding beneath itother elements 330 connected together by aflexible communication bus 325, according to an exemplary embodiment of the invention; In other exemplary embodiments of the invention, the flexible electrode array can comprise a shape forming a housing, or be placed on a housing, saidother elements 330 connected together are placed within said housing. - In an exemplary embodiment of the invention,
electrode array 300 is connected byflexible wires 320, as shown inFIG. 3B , toelements 330 andbattery 340, which constitute the elements ofstimulator 100. Alternatively,electrode array 300 is connected byflexible bus 325, as shown inFIG. 3C , toelements 330 andbattery 340, which constitute the elements ofstimulator 100. In some embodiments of the invention,battery 340 is not part of the elements ofsimulator 100. Alternative power sources tobattery 340 can include a capacitor, super capacitor, piezo-electric charging material, mechanical (induced by body or other organ or tissue movement) or chemical (such as ionic difference) power sources, coil or a coil having a ferrite core, and the like. In one exemplary embodiment of the invention action potential generated by neurons and nerve tissue across the nerve or muscle are gather via the electrode array and stored in a capacitor (not shown). The action potential translated into energy can be used to power the device of the invention. In an exemplary embodiment of the invention the housing is made of flexible bio compatible material such that the entire device is flexible. - The triangular tent shape of
array 300 and the other shapes disclosed herein, assists in forming contact betweenelectrodes 310 and the contact points at the base of the Genioglossus muscle, or more specifically near the compartments of the Genioglossus oblique fibers, and above the Geniohyoid muscle. Additionally, the triangular tent shape provide for a cavity or an opening underneath thereof that can be exploited to storeother elements 330 andbattery 340 or other power sources ofstimulator 100 by folding them up or placing them beneatharray 300 or within said housing (not shown). -
FIG. 3D is a schematic illustration offlexible electrode array 300 implanted at the base of the tongue, according to an exemplary embodiment of the invention. Optionally,electrode array 300 is designed so that when it is deployed,electrodes 310 will be in contact with theGenioglossus muscle 350 and more specifically adjacent to the Genioglossushorizontal fibers 350 and/or near theHypoglossal nerves 360, so thatelectrodes 310 will successfully be able to stimulate the Genioglossus horizontal compartment causing dilation of the pharynx during breathing. Optionally, the shape ofelectrode array 300 is especially efficient in stimulating theGenioglossus muscle 350, as this muscle has numerous motor end plates, located in various locations in contrast to many other muscles. -
FIGS. 4A-4E provide various exemplary shapes, of electrode arrays to be used to position the electrode array in proximity with the muscles or nerves that are to be stimulated by the electrodes of the array. The exemplary shapes include: - 1. A
flat surface 400; - 2. A
cylinder 410; - 3. A 3 dimensional
curved surface 420 with electrodes on the inner side to match a cylindrical muscle/nerve; - 4. A
flexible electrode pad 430 with branches of electrodes extending from a common center; and - 5. A
flexible electrode pad 440 with branches of electrodes of various sizes extending from a common center. - Optionally, other shapes may be used to maximize contact between the electrodes and the muscles/nerves. In an exemplary embodiment of the invention, the shape is designed to match the muscles/nerves that stimulator 100 is designed to stimulate.
-
FIG. 5 is a flow diagram 500 of a method of stimulating muscles or nerves usingimplantable stimulator 100 with an array of electrodes, according to an exemplary embodiment of the invention. In an exemplary embodiment of the invention, a medical practitioner implants (510) the device. The implantation process depends on the location and type of muscle/nerve to be stimulated. Optionally, due to the small size of stimulator 100 (e.g. with a length and width between 0.01 mm to 10 mm) a non-invasive procedure is preferable, for example by injecting the device using a hypodermic needle with local anesthesia only. Optionally, the use of a point and shoot insertion method is preferable, since it is more comfortable for the patient and less invasive. Optionally according to the present invention,stimulator 100 is advantageous since the multiplicity of electrodes relative to the number of contact points on the muscle/nerve and the ability to select the optimal electrodes for stimulation after implantation, reduce the need to adjust the position ofstimulator 100 responsive to actual stimulation during the insertion process. An example of use of astimulator 100 is in dealing with Obstructive Sleep Apnea patients. In an exemplary embodiment of the invention,stimulator 100 is implanted in the vicinity of the Hypoglossal nerve using a shallow transcutaneous approach. In other cases stimulator 100 is implanted into the Genioglossus muscle using an intraoral or transcutaneous/submandibular approach. - Optionally, after implanting
stimulator 100 the practitioner may adjust (520) the implanted stimulator responsive to an Ultrasound, MRI, CT, X-ray or other measurements before activating thestimulator 100. In some embodiments of the invention, the implantation is performed using a point and shoot process that does not require additional adjustments, however in some cases, usually depending on the type of stimulator and position of implantation in the patient's body further measurements may be required to verify accurate positioning, and further adjustments may be needed. In some embodiments of the invention, the implantation procedure is performed while using an imaging device (such as Ultrasound, MRI, CT, or X-ray) to guide the practitioner in locating the exact implantation site. - Once
stimulator 100 is positioned theelectrode array controller 120 dynamically selects (530) the electrodes fromelectrode array 110 that will be used to stimulate the muscle/nerve. - In some embodiments of the invention, the selection is performed manually by the practitioner, for example by communicating with stimulator 100 (e.g. with computer 180) and either instructing
stimulator 100 to activate single electrodes or groups of electrodes while observing the response, and/or instructingstimulator 100 to use theelectrode array 110 to measure electrical parameters such as resistance, conductance, or EMG signals, for each electrode or for groups of electrodes. Optionally, the practitioner may also measure a response via an external device, for example a surface EMG, fiber optic, manometer, polysomnograph, pulse oximeter, EEG, microphone. - In some embodiments of the invention, the selection may be performed automatically by
electrode array controller 120, whereinelectrode array controller 120 measures EMG signals, or other signals, and dynamically selects (530) the electrodes that will participate in the stimulation process responsive to the measurements. - In some embodiments of the invention,
stimulator 100 automatically, repeats the dynamic selection process before every use, or periodically (e.g. every day or every week or before the next use, or at predetermined intervals) to verify thatstimulator 100 has not moved and to remedy the situation if it has. Such predetermined intervals can be determined through a preprogrammed plan or reprogrammed when so required, or ad hoc as per each use. For example, the dynamic selection can be performed every few seconds or every few minutes or on an hourly basis and the like. - In some embodiments of the invention,
stimulator 100 is activated (550) responsive to various inputs accepted (540) bystimulator 100. Optionally, the inputs may be based on physiological parameters of the patient or may be based on commands from an external source such asexternal activation device 190. In an exemplary embodiment of the invention,external activation device 190 is used to activate the stimulator whenever the patient feels the need, for example when suffering pain or when interested that muscles controlled bystimulator 100 be activated. - Optionally, when treating OSA, the patient may activate
stimulator 100 when going to sleep, andstimulator 100 will perform muscle/nerve stimulation responsive to sensors that determine that the patient's tongue needs to be stimulated to enable the patient to breathe. Optionally,external activation device 190 may be a simple transmitter with one or more buttons or switches 195 to transmit signals tostimulator 100 and to select from a few options, for example to stimulate immediately, periodically or responsive to sensor measurements. Alternatively ageneral purpose computer 180 can be used toprogram stimulator 100 by transmitting simple or complex commands and receiving responses fromstimulator 100. In some embodiments of the invention,external activation device 190 supplies power tostimulator 100. Optionally,stimulator 100 may be activated (550) whenever power is provided. Alternatively, it may chargepower supply 160 and be activated (550) at a later time. - In some embodiments of the invention,
stimulator 100 may sense various physiological parameters of the patient withsensors 125, for example: - 1. Specific periodic vibrations or lack of vibrations from the patient's respiratory system;
- 2. Temperature in the vicinity of
stimulator 100, for example a higher temperature value responsive to the patient expiration in the vicinity of the implantedstimulator 100 and a lower temperature value responsive to the patient inspiration in the vicinity ofstimulator 100. A decrease in the temperature change may indicate reduction in breathing; - 3. Audio signals, for example, keeping track of the patient's heartbeat, breathing/snoring pattern, or breathing/snoring sounds. Optionally, a decrease in the volume of breathing sounds may indicate an OSA event;
- 4. EMG signals, for example, keeping track of the patient's muscle tone. Optionally, a decrease in the patient's muscle tone may indicate an OSA event. Optionally, an increase in the patient's respiratory auxiliary muscle tone may indicate an OSA event.
- In some embodiments of the invention, sensors are placed at other positions on the patient's body and they communicate wirelessly with
stimulator 100. - In some embodiments of the invention,
control 130 may perform a pre-programmed algorithm to weigh the results from various inputs and determine if to stimulate or not. Optionally,control 130 can be programmed to decide the specific stimulation protocol (e.g. pulse width, pulse amplitude, pulse shape). - In some embodiments of the invention,
stimulator 100 operates independently, without receiving any feedback. Optionally,stimulator 100 is pre-programmed to stimulate at specific times, for specific time duration, or to stimulate periodically, for example for 10 seconds every hour. - It should be appreciated that the above described methods and apparatus may be varied in many ways, including omitting or adding steps, changing the order of steps and the type of devices used. It should be appreciated that different features may be combined in different ways. In particular, not all the features shown above in a particular embodiment are necessary in every embodiment of the invention. Further combinations of the above features are also considered to be within the scope of some embodiments of the invention.
- It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather the scope of the present invention is defined only by the claims, which follow.
Claims (21)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/022,832 US20200406030A1 (en) | 2009-10-20 | 2020-09-16 | Implantable electrical stimulator |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/581,907 US10806926B2 (en) | 2009-10-20 | 2009-10-20 | Implantable electrical stimulator |
US17/022,832 US20200406030A1 (en) | 2009-10-20 | 2020-09-16 | Implantable electrical stimulator |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/581,907 Continuation US10806926B2 (en) | 2009-10-20 | 2009-10-20 | Implantable electrical stimulator |
Publications (1)
Publication Number | Publication Date |
---|---|
US20200406030A1 true US20200406030A1 (en) | 2020-12-31 |
Family
ID=43754790
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/581,907 Active US10806926B2 (en) | 2009-10-20 | 2009-10-20 | Implantable electrical stimulator |
US17/022,832 Pending US20200406030A1 (en) | 2009-10-20 | 2020-09-16 | Implantable electrical stimulator |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/581,907 Active US10806926B2 (en) | 2009-10-20 | 2009-10-20 | Implantable electrical stimulator |
Country Status (6)
Country | Link |
---|---|
US (2) | US10806926B2 (en) |
EP (2) | EP4218920A1 (en) |
AU (1) | AU2010309433B2 (en) |
CA (1) | CA2803485C (en) |
IL (2) | IL223774A (en) |
WO (1) | WO2011048590A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024088537A1 (en) * | 2022-10-26 | 2024-05-02 | Desmond Barry Keenan | System and method for peripheral nerve stimulation |
Families Citing this family (90)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9227053B2 (en) * | 2008-05-02 | 2016-01-05 | Medtronic, Inc. | Self expanding electrode cuff |
EP2323730B1 (en) | 2008-05-15 | 2016-11-16 | Inspire Medical Systems, Inc. | Apparatus for sensing respiratory pressure in an implantable stimulation system |
US8892210B2 (en) | 2008-07-02 | 2014-11-18 | Niveus Medical, Inc. | Devices, systems, and methods for automated optimization of energy delivery |
US9149386B2 (en) | 2008-08-19 | 2015-10-06 | Niveus Medical, Inc. | Devices and systems for stimulation of tissues |
EP2331201B1 (en) | 2008-10-01 | 2020-04-29 | Inspire Medical Systems, Inc. | System for treating sleep apnea transvenously |
EP2389224B1 (en) | 2008-11-19 | 2017-03-01 | Inspire Medical Systems, Inc. | Device treating sleep disordered breathing |
JP2012521864A (en) | 2009-03-31 | 2012-09-20 | インスパイア・メディカル・システムズ・インコーポレイテッド | Percutaneous access method in a system for treating sleep-related abnormal breathing |
US9849289B2 (en) * | 2009-10-20 | 2017-12-26 | Nyxoah SA | Device and method for snoring detection and control |
US9415216B2 (en) | 2009-10-20 | 2016-08-16 | Nyxoah SA | Devices for treatment of sleep apnea |
US9409013B2 (en) | 2009-10-20 | 2016-08-09 | Nyxoah SA | Method for controlling energy delivery as a function of degree of coupling |
WO2011060056A2 (en) | 2009-11-11 | 2011-05-19 | Niveus Mediacl, Inc. | Synergistic muscle activation device |
EP2544590B1 (en) | 2010-03-12 | 2018-02-14 | Inspire Medical Systems, Inc. | System for identifying a location for nerve stimulation |
US8788045B2 (en) | 2010-06-08 | 2014-07-22 | Bluewind Medical Ltd. | Tibial nerve stimulation |
US8983572B2 (en) | 2010-10-29 | 2015-03-17 | Inspire Medical Systems, Inc. | System and method for patient selection in treating sleep disordered breathing |
US9186504B2 (en) | 2010-11-15 | 2015-11-17 | Rainbow Medical Ltd | Sleep apnea treatment |
US9457186B2 (en) | 2010-11-15 | 2016-10-04 | Bluewind Medical Ltd. | Bilateral feedback |
EP2741813B1 (en) | 2011-08-11 | 2022-03-09 | Inspire Medical Systems, Inc. | System for selecting a stimulation protocol based on sensed respiratory effort |
US8855783B2 (en) | 2011-09-09 | 2014-10-07 | Enopace Biomedical Ltd. | Detector-based arterial stimulation |
EP2760535B1 (en) | 2011-09-30 | 2019-02-06 | Nyxoah SA | Apparatus for extending implant life using a dual power scheme |
WO2013111137A2 (en) | 2012-01-26 | 2013-08-01 | Rainbow Medical Ltd. | Wireless neurqstimulatqrs |
HK1203429A1 (en) | 2012-05-15 | 2015-10-30 | Imthera Medical, Inc. | Sublingual nerve stimulation for controlling the position of the patient's tongue |
US9468768B2 (en) | 2012-06-14 | 2016-10-18 | Case Western Reserve University | Delaying the onset of muscle fatigue associated with functional electrical stimulation |
US9468753B2 (en) * | 2012-06-14 | 2016-10-18 | Case Western Reserve University | System and method for stimulating motor units |
WO2014004526A1 (en) * | 2012-06-25 | 2014-01-03 | Niveus Medical, Inc. | Devices and systems for stimulation of tissues |
WO2014016701A2 (en) * | 2012-07-26 | 2014-01-30 | Adi Mashiach | External resonance matching between an implanted device and an external device |
WO2014087337A1 (en) | 2012-12-06 | 2014-06-12 | Bluewind Medical Ltd. | Delivery of implantable neurostimulators |
US8874220B2 (en) * | 2012-12-13 | 2014-10-28 | Nuraleve Inc. | Neurostimulation system, device, and method |
US10940311B2 (en) * | 2013-03-29 | 2021-03-09 | Neurometrix, Inc. | Apparatus and method for button-free control of a wearable transcutaneous electrical nerve stimulator using interactive gestures and other means |
EP3046621B1 (en) | 2013-09-16 | 2021-05-26 | The Board of Trustees of the Leland Stanford Junior University | Multi-element coupler for generation of electromagnetic energy |
ES2702906T3 (en) | 2013-11-19 | 2019-03-06 | Cleveland Clinic Found | System for treating obstructive sleep apnea using a neuromuscular stimulator |
US10195426B2 (en) | 2014-01-07 | 2019-02-05 | Invicta Medical, Inc. | Method and apparatus for treating sleep apnea |
US10004913B2 (en) | 2014-03-03 | 2018-06-26 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and apparatus for power conversion and data transmission in implantable sensors, stimulators, and actuators |
WO2015171213A1 (en) | 2014-05-09 | 2015-11-12 | The Board Of Trustees Of The Leland Stanford Junior University | Autofocus wireless power transfer to implantable devices in freely moving animals |
US20160336813A1 (en) | 2015-05-15 | 2016-11-17 | NeuSpera Medical Inc. | Midfield coupler |
EP4074273A1 (en) | 2014-05-18 | 2022-10-19 | NeuSpera Medical Inc. | Midfield coupler |
USD753316S1 (en) | 2014-12-03 | 2016-04-05 | Neurohabilitation Corporation | Non-invasive neurostimulation device |
US9415209B2 (en) | 2014-12-03 | 2016-08-16 | Neurohabilitation Corporation | Methods of manufacturing devices for the neurorehabilitation of a patient |
USD752236S1 (en) | 2014-12-03 | 2016-03-22 | Neurohabilitation Corporation | Non-invasive neurostimulation device |
USD759830S1 (en) | 2014-12-03 | 2016-06-21 | Neurohabilitation Corporation | Non-invasive neurostimulation device |
USD750794S1 (en) | 2014-12-03 | 2016-03-01 | Neurohabilitation Corporation | Non-invasive neurostimulation device |
USD750267S1 (en) | 2014-12-03 | 2016-02-23 | Neurohabilitation Corporation | Non-invasive neurostimulation device |
USD752766S1 (en) | 2014-12-03 | 2016-03-29 | Neurohabilitation Corporation | Non-invasive neurostimulation device |
US9656060B2 (en) | 2014-12-03 | 2017-05-23 | Neurohabilitation Corporation | Methods of manufacturing devices for the neurorehabilitation of a patient |
US9415210B2 (en) | 2014-12-03 | 2016-08-16 | Neurohabilitation Corporation | Methods of manufacturing devices for the neurorehabilitation of a patient |
USD751722S1 (en) | 2014-12-03 | 2016-03-15 | Neurohabilitation Corporation | Non-invasive neurostimulation device |
USD750265S1 (en) | 2014-12-03 | 2016-02-23 | Neurohabilitation Corporation | Non-invasive neurostimulation device |
USD750264S1 (en) | 2014-12-03 | 2016-02-23 | Neurohabilitation Corporation | Non-invasive neurostimulation device |
USD760397S1 (en) | 2014-12-03 | 2016-06-28 | Neurohabilitation Corporation | Non-invasive neurostimulation device |
USD749746S1 (en) | 2014-12-03 | 2016-02-16 | Neurohabilitation Corporation | Non-invasive neurostimulation device |
US9283377B1 (en) | 2014-12-03 | 2016-03-15 | Neurohabilitation Corporation | Devices for delivering non-invasive neuromodulation to a patient |
USD750266S1 (en) | 2014-12-03 | 2016-02-23 | Neurohabilitation Corporation | Non-invasive neurostimulation device |
US9072889B1 (en) * | 2014-12-03 | 2015-07-07 | Neurohabilitation Corporation | Systems for providing non-invasive neurorehabilitation of a patient |
US9616222B2 (en) | 2014-12-03 | 2017-04-11 | Neurohabilitation Corporation | Systems for providing non-invasive neurorehabilitation of a patient |
US9272133B1 (en) | 2014-12-03 | 2016-03-01 | Neurohabilitation Corporation | Methods of manufacturing devices for the neurorehabilitation of a patient |
US9993640B2 (en) | 2014-12-03 | 2018-06-12 | Neurohabilitation Corporation | Devices for delivering non-invasive neuromodulation to a patient |
USD753315S1 (en) | 2014-12-03 | 2016-04-05 | Neurohabilitation Corporation | Non-invasive neurostimulation device |
USD751214S1 (en) | 2014-12-03 | 2016-03-08 | Neurohabilitation Corporation | Non-invasive neurostimulation device |
US9981127B2 (en) | 2014-12-03 | 2018-05-29 | Neurohabilitation Corporation | Systems and methods for providing non-invasive neurorehabilitation of a patient |
US9789306B2 (en) | 2014-12-03 | 2017-10-17 | Neurohabilitation Corporation | Systems and methods for providing non-invasive neurorehabilitation of a patient |
US9227051B1 (en) | 2014-12-03 | 2016-01-05 | Neurohabilitation Corporation | Devices for delivering non-invasive neuromodulation to a patient |
USD751213S1 (en) | 2014-12-03 | 2016-03-08 | Neurohabilitation Corporation | Non-invasive neurostimulation device |
USD750268S1 (en) | 2014-12-03 | 2016-02-23 | Neurohabilitation Corporation | Non-invasive neurostimulation device |
US9764146B2 (en) | 2015-01-21 | 2017-09-19 | Bluewind Medical Ltd. | Extracorporeal implant controllers |
US10004896B2 (en) | 2015-01-21 | 2018-06-26 | Bluewind Medical Ltd. | Anchors and implant devices |
US9597521B2 (en) | 2015-01-21 | 2017-03-21 | Bluewind Medical Ltd. | Transmitting coils for neurostimulation |
US10898709B2 (en) | 2015-03-19 | 2021-01-26 | Inspire Medical Systems, Inc. | Stimulation for treating sleep disordered breathing |
DE102015106621A1 (en) * | 2015-04-29 | 2016-11-03 | Hella Kgaa Hueck & Co. | Access and driving authorization system with increased security against relay attacks by using movement sensors integrated in the authorization means |
US9782589B2 (en) | 2015-06-10 | 2017-10-10 | Bluewind Medical Ltd. | Implantable electrostimulator for improving blood flow |
US10195428B2 (en) | 2015-09-29 | 2019-02-05 | Medtronic, Inc. | Neural stimulation to treat sleep apnea |
US10105540B2 (en) | 2015-11-09 | 2018-10-23 | Bluewind Medical Ltd. | Optimization of application of current |
US9713707B2 (en) | 2015-11-12 | 2017-07-25 | Bluewind Medical Ltd. | Inhibition of implant migration |
US10084612B2 (en) | 2016-10-05 | 2018-09-25 | International Business Machines Corporation | Remote control with muscle sensor and alerting sensor |
US10124178B2 (en) | 2016-11-23 | 2018-11-13 | Bluewind Medical Ltd. | Implant and delivery tool therefor |
US20180353764A1 (en) | 2017-06-13 | 2018-12-13 | Bluewind Medical Ltd. | Antenna configuration |
WO2019032890A1 (en) | 2017-08-11 | 2019-02-14 | Inspire Medical Systems, Inc. | Cuff electrode |
US10426424B2 (en) | 2017-11-21 | 2019-10-01 | General Electric Company | System and method for generating and performing imaging protocol simulations |
US20200282215A1 (en) | 2019-03-06 | 2020-09-10 | Medtronic Xomed, LLC | Evaluating stimulation eficacy for treating sleep apnea and lingual muscle tone sensing system for improved osa therapy |
JP7543309B2 (en) | 2019-05-02 | 2024-09-02 | トゥウェルブ メディカル インコーポレイテッド | Systems and methods for improving sleep disordered breathing |
EP4045134A1 (en) | 2019-10-15 | 2022-08-24 | XII Medical, Inc. | Biased neuromodulation lead and method of using same |
WO2021076662A1 (en) | 2019-10-16 | 2021-04-22 | Invicta Medical, Inc. | Adjustable devices for treating sleep apnea, and associated systems and methods |
US20230355974A1 (en) * | 2020-09-18 | 2023-11-09 | Nyxoah SA | Pair of intelligent electric conductors |
EP4240241A4 (en) | 2020-11-04 | 2024-05-29 | Invicta Medical, Inc. | Implantable electrodes with remote power delivery for treating sleep apnea, and associated systems and methods |
US11691010B2 (en) | 2021-01-13 | 2023-07-04 | Xii Medical, Inc. | Systems and methods for improving sleep disordered breathing |
WO2022225789A1 (en) * | 2021-04-19 | 2022-10-27 | W. L. Gore & Associates, Inc. | Apparatuses, systems, and methods for percutaneous delivery of neurostimulation arrays |
EP4340863A4 (en) * | 2021-05-20 | 2025-02-26 | Invicta Medical, Inc. | METHODS OF PLACING IMPLANTABLE ELECTRODES FOR THE TREATMENT OF SLEEP APNEA AND RELATED SYSTEMS |
EP4355412A1 (en) * | 2021-06-14 | 2024-04-24 | Rehabtronics Inc. | Systems for mitigating pressure injuries |
US11400299B1 (en) | 2021-09-14 | 2022-08-02 | Rainbow Medical Ltd. | Flexible antenna for stimulator |
CN114795230B (en) * | 2022-03-29 | 2023-07-07 | 北京理工大学 | Implanted wireless nerve sensor for recording brain electrical signals |
US11964154B1 (en) | 2022-12-22 | 2024-04-23 | Invicta Medical, Inc. | Signal delivery devices to treat sleep apnea, and associated methods and systems |
WO2024196803A2 (en) | 2023-03-17 | 2024-09-26 | Invicta Medical, Inc. | Methods for positioning signal delivery devices to treat sleep apnea, and associated devices and treatments |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0663137B1 (en) * | 1993-07-01 | 2002-10-02 | The University Of Melbourne | Cochlear implant devices |
US20080103545A1 (en) * | 2006-10-13 | 2008-05-01 | Apnex Medical, Inc. | Obstructive sleep apnea treatment devices, systems and methods |
US20130123568A1 (en) * | 2010-07-01 | 2013-05-16 | Stimdesigns Llc | Universal closed-loop electrical stimulation system |
US20150224326A1 (en) * | 2012-05-29 | 2015-08-13 | Autonomix Medical, Inc. | Endoscopic sympathectomy systems and methods |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US727749A (en) * | 1901-10-29 | 1903-05-12 | William E Cook | Rotary pump. |
US4837049A (en) | 1986-06-17 | 1989-06-06 | Alfred E. Mann Foundation For Scientific Research | Method of making an electrode array |
US5174287A (en) | 1991-05-28 | 1992-12-29 | Medtronic, Inc. | Airway feedback measurement system responsive to detected inspiration and obstructive apnea event |
US5540733A (en) | 1994-09-21 | 1996-07-30 | Medtronic, Inc. | Method and apparatus for detecting and treating obstructive sleep apnea |
US5485851A (en) | 1994-09-21 | 1996-01-23 | Medtronic, Inc. | Method and apparatus for arousal detection |
US6051017A (en) | 1996-02-20 | 2000-04-18 | Advanced Bionics Corporation | Implantable microstimulator and systems employing the same |
EP0892654B1 (en) | 1996-04-04 | 2003-06-11 | Medtronic, Inc. | Apparatus for living tissue stimulation and recording techniques |
JP2001507207A (en) * | 1996-05-01 | 2001-06-05 | イマアーレクス・フアーマシユーチカル・コーポレーシヨン | Methods for delivering compounds to cells |
AU1093099A (en) * | 1997-10-17 | 1999-05-10 | Penn State Research Foundation; The | Muscle stimulating device and method for diagnosing and treating a breathin g disorder |
WO2000006249A2 (en) | 1998-07-27 | 2000-02-10 | Case Western Reserve University | Method and apparatus for closed-loop stimulation of the hypoglossal nerve in human patients to treat obstructive sleep apnea |
US6240316B1 (en) | 1998-08-14 | 2001-05-29 | Advanced Bionics Corporation | Implantable microstimulation system for treatment of sleep apnea |
US6275737B1 (en) | 1998-10-14 | 2001-08-14 | Advanced Bionics Corporation | Transcutaneous transmission pouch |
US6393325B1 (en) * | 1999-01-07 | 2002-05-21 | Advanced Bionics Corporation | Directional programming for implantable electrode arrays |
US6636767B1 (en) | 1999-09-29 | 2003-10-21 | Restore Medical, Inc. | Implanatable stimulation device for snoring treatment |
US20070173893A1 (en) | 2000-10-20 | 2007-07-26 | Pitts Walter C | Method and apparatus for preventing obstructive sleep apnea |
US7519421B2 (en) * | 2001-01-16 | 2009-04-14 | Kenergy, Inc. | Vagal nerve stimulation using vascular implanted devices for treatment of atrial fibrillation |
US6788975B1 (en) | 2001-01-30 | 2004-09-07 | Advanced Bionics Corporation | Fully implantable miniature neurostimulator for stimulation as a therapy for epilepsy |
US6625494B2 (en) | 2001-03-30 | 2003-09-23 | Neurocontrol Corporation | Systems and methods for performing prosthetic or therapeutic neuromuscular stimulation using a universal external controller providing different selectable neuromuscular stimulation functions |
US7132173B2 (en) | 2002-06-28 | 2006-11-07 | Advanced Bionics Corporation | Self-centering braze assembly |
US7277749B2 (en) * | 2003-01-15 | 2007-10-02 | Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California | Treatments for snoring using injectable neuromuscular stimulators |
US8014878B2 (en) | 2005-04-28 | 2011-09-06 | Second Sight Medical Products, Inc. | Flexible circuit electrode array |
US7636602B2 (en) | 2003-04-02 | 2009-12-22 | Neurostream Technologies General Partnership | Fully implantable nerve signal sensing and stimulation device and method for treating foot drop and other neurological disorders |
JP2007501067A (en) | 2003-08-01 | 2007-01-25 | ノーススター ニューロサイエンス インコーポレイテッド | Apparatus and method for applying neural stimulation to patient |
US7680537B2 (en) | 2003-08-18 | 2010-03-16 | Cardiac Pacemakers, Inc. | Therapy triggered by prediction of disordered breathing |
US7272443B2 (en) | 2004-03-26 | 2007-09-18 | Pacesetter, Inc. | System and method for predicting a heart condition based on impedance values using an implantable medical device |
US8813753B2 (en) | 2004-09-21 | 2014-08-26 | Medtronic Xomed, Inc. | Implantable obstructive sleep apnea sensor |
TWI246914B (en) | 2004-12-30 | 2006-01-11 | Ind Tech Res Inst | Flexible implantable electrical stimulator array |
US7680538B2 (en) | 2005-03-31 | 2010-03-16 | Case Western Reserve University | Method of treating obstructive sleep apnea using electrical nerve stimulation |
EP1904160B1 (en) | 2005-06-09 | 2011-12-21 | Medtronic, Inc. | Peripheral nerve field stimulation and spinal cord stimulation |
KR100683790B1 (en) * | 2005-07-12 | 2007-02-15 | 삼성에스디아이 주식회사 | Hydrogen-ion conductive composite membrane using inorganic conductors and its manufacturing method |
US7725195B2 (en) | 2006-02-16 | 2010-05-25 | Imthera Medical, Inc. | RFID-based apparatus, system, and method for therapeutic treatment of obstructive sleep apnea |
US7909038B2 (en) | 2006-04-20 | 2011-03-22 | Pavad Medical, Inc. | Tongue stabilization device and methods of using the same |
US20080021506A1 (en) | 2006-05-09 | 2008-01-24 | Massachusetts General Hospital | Method and device for the electrical treatment of sleep apnea and snoring |
US7996088B2 (en) | 2006-07-26 | 2011-08-09 | Cyberonics, Inc. | Vagus nerve stimulation by electrical signals for controlling cerebellar tremor |
US7680536B2 (en) * | 2006-08-17 | 2010-03-16 | Cardiac Pacemakers, Inc. | Capture threshold estimation for alternate pacing vectors |
US8160696B2 (en) | 2008-10-03 | 2012-04-17 | Lockheed Martin Corporation | Nerve stimulator and method using simultaneous electrical and optical signals |
US20080132962A1 (en) | 2006-12-01 | 2008-06-05 | Diubaldi Anthony | System and method for affecting gatric functions |
US7890178B2 (en) | 2006-12-15 | 2011-02-15 | Medtronic Xomed, Inc. | Method and apparatus for assisting deglutition |
WO2009018394A1 (en) | 2007-07-31 | 2009-02-05 | Schneider M Bret | Device and method for hypertension treatment by non-invasive stimulation to vascular baroreceptors |
AU2009302591B2 (en) | 2008-10-09 | 2014-08-07 | Imthera Medical, Inc. | Method of stimulating a hypoglossal nerve for controlling the position of a patient's tongue |
US9227075B2 (en) * | 2008-12-03 | 2016-01-05 | Boston Scientific Neuromodulation Corporation | External charger with adjustable alignment indicator |
US20100191136A1 (en) | 2009-01-26 | 2010-07-29 | Wolford Danette K | System, pad and method for monitoring a sleeping person to detect an apnea state condition |
EP2408517A1 (en) | 2009-03-03 | 2012-01-25 | Medtronic, Inc | Electrical stimulation therapy to promote gastric distention for obesity management |
AU2010291938B2 (en) | 2009-09-14 | 2016-03-10 | Sleep Methods, Inc. | System and method for training and promoting a conditioned reflex intervention during sleep |
US8585617B2 (en) | 2009-12-21 | 2013-11-19 | Nyxoah SA | Diagnosis and prediction of obstructive sleep apnea |
-
2009
- 2009-10-20 US US12/581,907 patent/US10806926B2/en active Active
-
2010
- 2010-10-19 EP EP23170585.6A patent/EP4218920A1/en active Pending
- 2010-10-19 EP EP10781533A patent/EP2558158A1/en not_active Ceased
- 2010-10-19 CA CA2803485A patent/CA2803485C/en active Active
- 2010-10-19 AU AU2010309433A patent/AU2010309433B2/en active Active
- 2010-10-19 WO PCT/IL2010/000856 patent/WO2011048590A1/en active Application Filing
-
2012
- 2012-12-20 IL IL223774A patent/IL223774A/en active IP Right Grant
-
2017
- 2017-05-11 IL IL252231A patent/IL252231B/en active IP Right Grant
-
2020
- 2020-09-16 US US17/022,832 patent/US20200406030A1/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0663137B1 (en) * | 1993-07-01 | 2002-10-02 | The University Of Melbourne | Cochlear implant devices |
US20080103545A1 (en) * | 2006-10-13 | 2008-05-01 | Apnex Medical, Inc. | Obstructive sleep apnea treatment devices, systems and methods |
US20080103407A1 (en) * | 2006-10-13 | 2008-05-01 | Apnex Medical, Inc. | Obstructive sleep apnea treatment devices, systems and methods |
US20130123568A1 (en) * | 2010-07-01 | 2013-05-16 | Stimdesigns Llc | Universal closed-loop electrical stimulation system |
US20150224326A1 (en) * | 2012-05-29 | 2015-08-13 | Autonomix Medical, Inc. | Endoscopic sympathectomy systems and methods |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024088537A1 (en) * | 2022-10-26 | 2024-05-02 | Desmond Barry Keenan | System and method for peripheral nerve stimulation |
Also Published As
Publication number | Publication date |
---|---|
US10806926B2 (en) | 2020-10-20 |
EP4218920A1 (en) | 2023-08-02 |
AU2010309433B2 (en) | 2015-10-22 |
IL252231B (en) | 2019-07-31 |
AU2010309433A1 (en) | 2013-08-29 |
IL252231A0 (en) | 2017-07-31 |
CA2803485A1 (en) | 2011-04-28 |
WO2011048590A1 (en) | 2011-04-28 |
EP2558158A1 (en) | 2013-02-20 |
US20110093036A1 (en) | 2011-04-21 |
IL223774A (en) | 2017-05-29 |
CA2803485C (en) | 2022-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20200406030A1 (en) | Implantable electrical stimulator | |
US11478648B2 (en) | Antenna and methods of use for an implantable nerve stimulator | |
US11351380B2 (en) | Implantable stimulation power receiver, systems and methods | |
CN105873508B (en) | Implantation material unit means of delivery | |
US7899541B2 (en) | Systems and methods for implantable leadless gastrointestinal tissue stimulation | |
CA2641821C (en) | An rfid-based apparatus, system, and method for therapeutic treatment of a patient | |
EP3532154B1 (en) | Autotitration of therapy using detected electrical activity | |
US20070100388A1 (en) | Implantable medical device providing adaptive neurostimulation therapy for incontinence | |
AU2012201366B8 (en) | An RFID based apparatus, system, and method for therapeutic treatment of a patient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: NYXOAH SA, BELGIUM Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MASHIACH, ADI;REEL/FRAME:053791/0973 Effective date: 20091020 Owner name: MAN & SCIENCE SA, BELGIUM Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NYXOAH SA;REEL/FRAME:053792/0065 Effective date: 20110830 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |